Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 USD | +2.09% |
|
-2.00% | -37.32% |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-37.32% | 283M | C | ||
+15.19% | 121B | B+ | ||
+19.91% | 114B | B+ | ||
+8.24% | 23.61B | B | ||
-19.80% | 20.43B | B+ | ||
-16.19% | 16.55B | A- | ||
-13.45% | 16.45B | B | ||
-44.35% | 15.59B | A- | ||
+66.67% | 15.19B | C+ | ||
+2.13% | 13.54B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MGTX Stock
- Ratings MeiraGTx Holdings plc